Views & Analysis The future for pharma marketing is personal Marco Ricci reports from the eyeforpharma Marketing and Consumer Innovation Europe 2017 conference.
Views & Analysis The evolution of multichannel marketing into touchpoints How far is the industry from fully embracing modern-day ‘touchpoint’ marketing?
Views & Analysis Pharma websites: a great time to get closer to patients Wary US consumers present opportunities for pharma to become trusted resources for health information.
Views & Analysis Learning from a successful ophthalmology brand launch Applying learnings from a successful ophthalmology brand launch to other therapy areas and pharmaceutical brands.
Views & Analysis What does your pharma brand mean to patients? Pharma companies can differentiate themselves and win support if they take actions that patients find informative.
Views & Analysis The future of brand management What pharma brand management must entail to ensure pharma retains its position and maintains sales.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
